Miguel Gonzalez Velez: New Study on Real-World HER2-Mutant NSCLC Outcomes

Personalized Treatment Strategies for HER2-Positive Gastroesophageal Adenocarcinoma

This article discusses evolving strategies for personalized treatment of HER2-positive gastroesophageal adenocarcinoma (GEA). It features in

Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer | NEJM

Disclosure Statement: Dr. Enriqueta Felip's Financial Relationships in Thoracic Oncology

This article presents a disclosure statement for Dr. Enriqueta Felip, a professor and thoracic oncology director at Vall d'Hebron University

14-protein plasma signature predicts lung cancer risk years before diagnosis and identifies candidates for preventive therapy

This article presents a scientific study identifying a 14-protein plasma signature that can predict lung cancer risk more than 5 years befor

14-protein plasma signature predicts lung cancer risk years before diagnosis and identifies candidates for preventive therapy

This article presents a scientific study on lung cancer risk prediction using a 14-protein plasma signature identified through machine learn

OHSU logra un gran avance en la ciencia médica con las terapias celulares